Varicella Attenuated Live Vaccine Industry Research Report 2024

Varicella Attenuated Live Vaccine Industry Research Report 2024


A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.

Highlights

The global Varicella Attenuated Live Vaccine market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
For the major players of Varicella Attenuated Live Vaccine, Merck maintained its first place in the ranking in 2019, followed by BCHT, Shanghai Institute, GSK and Keygen. Top 5 players accounted for about 95% of the Global Varicella Attenuated Live Vaccine revenue market share in 2019.
The sales market for Varicella Attenuated Live Vaccine was divided into five geographic regions. Asia-Pacific occupied the largest sales market share with about 58% in 2019. It is followed by North America and Europe with about 18% and about 13% respectively, while other regions have smaller market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Varicella Attenuated Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Attenuated Live Vaccine.
The Varicella Attenuated Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Varicella Attenuated Live Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Attenuated Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck
BCHT
Shanghai Institute
GSK
Keygen
Green Cross
Biken
Shanghai Rongsheng Biotech
Changchun Changsheng Life Sciences Limited

Product Type Insights

Global markets are presented by Varicella Attenuated Live Vaccine type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Varicella Attenuated Live Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Varicella Attenuated Live Vaccine segment by Type

Monovalent Vaccine
Combination Vaccine

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Varicella Attenuated Live Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Varicella Attenuated Live Vaccine market.
Varicella Attenuated Live Vaccine segment by Application

Kids Injection
Adults Injection

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Varicella Attenuated Live Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Attenuated Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Varicella Attenuated Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Varicella Attenuated Live Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Attenuated Live Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Varicella Attenuated Live Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Varicella Attenuated Live Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Varicella Attenuated Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Varicella Attenuated Live Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Varicella Attenuated Live Vaccine Sales (2019-2030)
2.2.3 Global Varicella Attenuated Live Vaccine Market Average Price (2019-2030)
2.3 Varicella Attenuated Live Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
2.4 Varicella Attenuated Live Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Kids Injection
2.4.3 Adults Injection
3 Market Competitive Landscape by Manufacturers
3.1 Global Varicella Attenuated Live Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Varicella Attenuated Live Vaccine Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Varicella Attenuated Live Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Varicella Attenuated Live Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Varicella Attenuated Live Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Varicella Attenuated Live Vaccine, Product Type & Application
3.8 Global Manufacturers of Varicella Attenuated Live Vaccine, Date of Enter into This Industry
3.9 Global Varicella Attenuated Live Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Varicella Attenuated Live Vaccine Product Portfolio
4.1.5 Merck Recent Developments
4.2 BCHT
4.2.1 BCHT Company Information
4.2.2 BCHT Business Overview
4.2.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 BCHT Varicella Attenuated Live Vaccine Product Portfolio
4.2.5 BCHT Recent Developments
4.3 Shanghai Institute
4.3.1 Shanghai Institute Company Information
4.3.2 Shanghai Institute Business Overview
4.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Shanghai Institute Varicella Attenuated Live Vaccine Product Portfolio
4.3.5 Shanghai Institute Recent Developments
4.4 GSK
4.4.1 GSK Company Information
4.4.2 GSK Business Overview
4.4.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 GSK Varicella Attenuated Live Vaccine Product Portfolio
4.4.5 GSK Recent Developments
4.5 Keygen
4.5.1 Keygen Company Information
4.5.2 Keygen Business Overview
4.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Keygen Varicella Attenuated Live Vaccine Product Portfolio
4.5.5 Keygen Recent Developments
4.6 Green Cross
4.6.1 Green Cross Company Information
4.6.2 Green Cross Business Overview
4.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Green Cross Varicella Attenuated Live Vaccine Product Portfolio
4.6.5 Green Cross Recent Developments
4.7 Biken
4.7.1 Biken Company Information
4.7.2 Biken Business Overview
4.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Biken Varicella Attenuated Live Vaccine Product Portfolio
4.7.5 Biken Recent Developments
4.8 Shanghai Rongsheng Biotech
4.8.1 Shanghai Rongsheng Biotech Company Information
4.8.2 Shanghai Rongsheng Biotech Business Overview
4.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Portfolio
4.8.5 Shanghai Rongsheng Biotech Recent Developments
4.9 Changchun Changsheng Life Sciences Limited
4.9.1 Changchun Changsheng Life Sciences Limited Company Information
4.9.2 Changchun Changsheng Life Sciences Limited Business Overview
4.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Portfolio
4.9.5 Changchun Changsheng Life Sciences Limited Recent Developments
5 Global Varicella Attenuated Live Vaccine Market Scenario by Region
5.1 Global Varicella Attenuated Live Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Varicella Attenuated Live Vaccine Sales by Region: 2019-2030
5.2.1 Global Varicella Attenuated Live Vaccine Sales by Region: 2019-2024
5.2.2 Global Varicella Attenuated Live Vaccine Sales by Region: 2025-2030
5.3 Global Varicella Attenuated Live Vaccine Revenue by Region: 2019-2030
5.3.1 Global Varicella Attenuated Live Vaccine Revenue by Region: 2019-2024
5.3.2 Global Varicella Attenuated Live Vaccine Revenue by Region: 2025-2030
5.4 North America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
5.4.1 North America Varicella Attenuated Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Varicella Attenuated Live Vaccine Sales by Country (2019-2030)
5.4.3 North America Varicella Attenuated Live Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Varicella Attenuated Live Vaccine Market Facts & Figures by Country
5.5.1 Europe Varicella Attenuated Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Varicella Attenuated Live Vaccine Sales by Country (2019-2030)
5.5.3 Europe Varicella Attenuated Live Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Varicella Attenuated Live Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Varicella Attenuated Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Varicella Attenuated Live Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Varicella Attenuated Live Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
5.7.1 Latin America Varicella Attenuated Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Varicella Attenuated Live Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Varicella Attenuated Live Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Varicella Attenuated Live Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Varicella Attenuated Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Varicella Attenuated Live Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
6.1.1 Global Varicella Attenuated Live Vaccine Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
6.2.1 Global Varicella Attenuated Live Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Varicella Attenuated Live Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
7.1.1 Global Varicella Attenuated Live Vaccine Sales by Application (2019-2030) & (K Doses)
7.1.2 Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
6.2.1 Global Varicella Attenuated Live Vaccine Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Varicella Attenuated Live Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Varicella Attenuated Live Vaccine Value Chain Analysis
8.1.1 Varicella Attenuated Live Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Varicella Attenuated Live Vaccine Production Mode & Process
8.2 Varicella Attenuated Live Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Varicella Attenuated Live Vaccine Distributors
8.2.3 Varicella Attenuated Live Vaccine Customers
9 Global Varicella Attenuated Live Vaccine Analyzing Market Dynamics
9.1 Varicella Attenuated Live Vaccine Industry Trends
9.2 Varicella Attenuated Live Vaccine Industry Drivers
9.3 Varicella Attenuated Live Vaccine Industry Opportunities and Challenges
9.4 Varicella Attenuated Live Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings